News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ExonHit Therapeutics Inc.: AclarusDx®: Launch of Observational Study in France



12/12/2011 10:49:57 AM

PARIS--(BUSINESS WIRE)--Regulatory News:

•AclarusDx® real-life observational study •First patient should be recruited in December Exonhit (Paris:ALEHT) announced today the launch of its observational study in France aimed at evaluating the performance of AclarusDx®, a blood-based test intended to aid in the diagnosis of Alzheimer’s disease (AD), in patients consulting for the first time with a specialized memory center for AD diagnostic work-up. This real-life study named DIALOG (DIagnostic ALzheimer cOGnitif) is sponsored by Exonhit and has received all regulatory approvals.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES